Anti-Claudin-3 monoclonal antibody, and treatment and diagnosis of cancer using the same

Details for Australian Patent Application No. 2007332473 (hide)

Owner Forerunner Pharma Research Co., Ltd.

Inventors Yoshida, Kenji

Agent Spruson & Ferguson

Pub. Number AU-B-2007332473

PCT Pub. Number WO2008/072723

Priority 2006-336555 14.12.06 JP

Filing date 14 December 2007

Wipo publication date 19 June 2008

Acceptance publication date 27 September 2012

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 Antineoplastic agents

A61P 35/04 Antineoplastic agents

A61P 43/00 Drugs for specific purposes, not provided for in groups

C07K 16/46 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

G01N 33/574 Investigating or analysing materials by specific methods not covered by groups - for cancer

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

C12P 21/08 Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/072723 Priority application(s): WO2008/072723

27 September 2012 Application Accepted

  Published as AU-B-2007332473

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007332476-1-phenyl 1-thio-D-glucitol derivative

2007332452-Method for measuring 1,5-anhydroglucitol in whole blood, and sensor chip and measurement kit to be used in the method